Coldewey, Sina M. https://orcid.org/0000-0002-7130-0006
Neu, Charles
Bloos, Frank
Baumbach, Philipp
Schumacher, Ulrike
Bauer, Michael
Reuken, Philipp
Stallmach, Andreas
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (03COV08)
Universitätsklinikum Jena
Article History
Received: 29 April 2022
Accepted: 18 July 2022
First Online: 2 September 2022
Declarations
:
: The study in its current version (version 1.0, 10 May 2021) was approved by the Ethics Committee of the Friedrich-Schiller-University Jena (2021-2236-AMG-ff, 27 May 2021) and the Paul-Ehrlich-Institute (4513/01, 27 May 2021) and is in accordance with the Declaration of Helsinki and the AMG.Written informed consent will be obtained from all patients participating in this study (s. Methods section for further details).Patients are insured against potential harm from trial participation as required by AMG.
: No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Consent materials are available from the corresponding author on request.
: Outside of the study, AS has received consulting fees from AbbVie, Amgen, Celltrion, Janssen, MSD, Mundipharma, and Takeda; lecture fees and support for travel accommodation from AbbVie, Amgen, FalkFoundation, Janssen, MSD, and Takeda; and research funding from Abbvie and Celltrion. All other authors declare no conflict of interest.